Development of magnesium chelate (‘magnesia’) by Master Pharm S.A. (Q101105): Difference between revisions
Jump to navigation
Jump to search
(Removed claim: summary (P836): The project involves the R & D work leading to the development of magnesium chelate of technologies. A new active substance — chelated magnesium is used in a supplement to the next generation of diets. This supplement will permit the supply of magnesium in the form of a chelating agent in the form of chelate of magnesium ion time parameters and bioavailability, and consequently an optimised impact on maintaining the appropriate level of magnes...) |
(Created claim: summary (P836): The subject of the project are R & D works leading to the development of magnesium chelation technology. The developed new active substance – chelated magnesium – will be used in the supplement of the new generation of diet. This supplement will allow the supply of magnesium in the form of chelate characterised by balanced parameters of the release time of magnesium ions and bioavailability, and consequently optimised influence in maintaining th...) |
||||||||||||||
| Property / summary | |||||||||||||||
The subject of the project are R & D works leading to the development of magnesium chelation technology. The developed new active substance – chelated magnesium – will be used in the supplement of the new generation of diet. This supplement will allow the supply of magnesium in the form of chelate characterised by balanced parameters of the release time of magnesium ions and bioavailability, and consequently optimised influence in maintaining the proper level of magnesium in the body R & D activities leading to the development of magnesium chelation technology will include carrying out: industrial research in the field of: — selection of central metal precursor, – choice of chelator, – selection of synthetic path, – verification of synthetic path on a laboratory scale. b) experimental development work in the scope of: — verification of synthetic paths on a quarter-technical and semi-technical scale, – development of the final form of technology together with tests under real conditions. The project will allow to develop an innovative product – a new generation dietary supplement based on the use of new magnesium chelate. R & D works will allow for a stage of advancement of innovative solutions allowing them to market – as they include their tests and validation in the first production. Output indicators: Number of enterprises receiving support (C001): 1 Number of enterprises receiving grants (CO02): 1 Private investment complementing public support to enterprises (grants) (CO06): 357257,70 PLN Number of enterprises supported by R & D activities: 1 Number of R & D activities carried out: 1 Number of R & D projects implemented: 1 Direct result indicator: Number of commercialised R & D results carried out by the company in the framework of the project: 1 The dietary supplement developed as part of the project will be directed to the markets: Polish and foreign, both retail (sale under own brand (English) | |||||||||||||||
| Property / summary: The subject of the project are R & D works leading to the development of magnesium chelation technology. The developed new active substance – chelated magnesium – will be used in the supplement of the new generation of diet. This supplement will allow the supply of magnesium in the form of chelate characterised by balanced parameters of the release time of magnesium ions and bioavailability, and consequently optimised influence in maintaining the proper level of magnesium in the body R & D activities leading to the development of magnesium chelation technology will include carrying out: industrial research in the field of: — selection of central metal precursor, – choice of chelator, – selection of synthetic path, – verification of synthetic path on a laboratory scale. b) experimental development work in the scope of: — verification of synthetic paths on a quarter-technical and semi-technical scale, – development of the final form of technology together with tests under real conditions. The project will allow to develop an innovative product – a new generation dietary supplement based on the use of new magnesium chelate. R & D works will allow for a stage of advancement of innovative solutions allowing them to market – as they include their tests and validation in the first production. Output indicators: Number of enterprises receiving support (C001): 1 Number of enterprises receiving grants (CO02): 1 Private investment complementing public support to enterprises (grants) (CO06): 357257,70 PLN Number of enterprises supported by R & D activities: 1 Number of R & D activities carried out: 1 Number of R & D projects implemented: 1 Direct result indicator: Number of commercialised R & D results carried out by the company in the framework of the project: 1 The dietary supplement developed as part of the project will be directed to the markets: Polish and foreign, both retail (sale under own brand (English) / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / summary: The subject of the project are R & D works leading to the development of magnesium chelation technology. The developed new active substance – chelated magnesium – will be used in the supplement of the new generation of diet. This supplement will allow the supply of magnesium in the form of chelate characterised by balanced parameters of the release time of magnesium ions and bioavailability, and consequently optimised influence in maintaining the proper level of magnesium in the body R & D activities leading to the development of magnesium chelation technology will include carrying out: industrial research in the field of: — selection of central metal precursor, – choice of chelator, – selection of synthetic path, – verification of synthetic path on a laboratory scale. b) experimental development work in the scope of: — verification of synthetic paths on a quarter-technical and semi-technical scale, – development of the final form of technology together with tests under real conditions. The project will allow to develop an innovative product – a new generation dietary supplement based on the use of new magnesium chelate. R & D works will allow for a stage of advancement of innovative solutions allowing them to market – as they include their tests and validation in the first production. Output indicators: Number of enterprises receiving support (C001): 1 Number of enterprises receiving grants (CO02): 1 Private investment complementing public support to enterprises (grants) (CO06): 357257,70 PLN Number of enterprises supported by R & D activities: 1 Number of R & D activities carried out: 1 Number of R & D projects implemented: 1 Direct result indicator: Number of commercialised R & D results carried out by the company in the framework of the project: 1 The dietary supplement developed as part of the project will be directed to the markets: Polish and foreign, both retail (sale under own brand (English) / qualifier | |||||||||||||||
point in time: 16 October 2020
| |||||||||||||||
Revision as of 00:11, 16 October 2020
Project in Poland financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Development of magnesium chelate (‘magnesia’) by Master Pharm S.A. |
Project in Poland financed by DG Regio |
Statements
561,577.5 zloty
0 references
891,070.0 zloty
0 references
63.02 percent
0 references
1 October 2018
0 references
31 March 2020
0 references
MASTER PHARM SPÓŁKA AKCYJNA
0 references
51°46'23.2"N, 19°28'42.2"E
0 references
Przedmiotem projektu są prace B+R prowadzące do opracowania technologii chelatowania magnezu. Opracowana nowa substancja aktywna - chelatowany magnez - zostanie zastosowana w suplemencie diety nowej generacji. Suplement ten pozwoli na dostarczanie magnezu w formie chelatu charakteryzującego się zbalansowanymi parametrami czasu uwalniania jonów magnezu oraz biodostępności, i w konsekwencji zoptymalizowanym wpływem w zakresie utrzymywania właściwego poziomu magnezu w organizmie Prace B+R prowadzące do opracowania technologii chelatowania magnezu będą obejmowały przeprowadzenie: a) badań przemysłowych w zakresie: - wyboru prekursora metalu centralnego, - wyboru chelatora, - wyboru ścieżki syntetycznej, - weryfikacji ścieżki syntetycznej w skali laboratoryjnej. b) eksperymentalnych prac rozwojowych w zakresie: - weryfikacji ścieżki syntetycznej w skali ćwierćtechnicznej i półtechnicznej, - opracowania ostatecznej postaci technologii wraz z testami w warunkach rzeczywistych. Projekt pozwoli na opracowanie innowacyjnego w skali świata produktu - suplementu diety nowej generacji opartego na wykorzystaniu nowego chelatu magnezu. Prace B+R pozwolą na uzyskanie etapu zaawansowania innowacyjnych rozwiązań pozwalającego na ich urynkowienie - obejmują bowiem ich testy i walidację w ramach pierwszej produkcji. Wskaźniki produktu: Liczba przedsiębiorstw otrzymujących wsparcie (C001): 1 Liczba przedsiębiorstw otrzymujących dotacje (CO02): 1 Inwestycje prywatne uzupełniające wsparcie publiczne dla przedsiębiorstw (dotacje) (CO06): 357257,70 PLN Liczba przedsiębiorstw wspartych w zakresie prowadzenia prac B+R: 1 Liczba realizowanych prac B+R: 1 Liczba realizowanych projektów B+R: 1 Wskaźnik rezultatu bezpośredniego: Liczba skomercjalizowanych wyników prac B+R prowadzonych przez przedsiębiorstwo w ramach projektu: 1 Suplement diety opracowany w ramach projektu zostanie skierowany na rynki: polski i zagraniczny, zarówno detaliczny (sprzedaż pod własną mark (Polish)
0 references
The subject of the project are R & D works leading to the development of magnesium chelation technology. The developed new active substance – chelated magnesium – will be used in the supplement of the new generation of diet. This supplement will allow the supply of magnesium in the form of chelate characterised by balanced parameters of the release time of magnesium ions and bioavailability, and consequently optimised influence in maintaining the proper level of magnesium in the body R & D activities leading to the development of magnesium chelation technology will include carrying out: industrial research in the field of: — selection of central metal precursor, – choice of chelator, – selection of synthetic path, – verification of synthetic path on a laboratory scale. b) experimental development work in the scope of: — verification of synthetic paths on a quarter-technical and semi-technical scale, – development of the final form of technology together with tests under real conditions. The project will allow to develop an innovative product – a new generation dietary supplement based on the use of new magnesium chelate. R & D works will allow for a stage of advancement of innovative solutions allowing them to market – as they include their tests and validation in the first production. Output indicators: Number of enterprises receiving support (C001): 1 Number of enterprises receiving grants (CO02): 1 Private investment complementing public support to enterprises (grants) (CO06): 357257,70 PLN Number of enterprises supported by R & D activities: 1 Number of R & D activities carried out: 1 Number of R & D projects implemented: 1 Direct result indicator: Number of commercialised R & D results carried out by the company in the framework of the project: 1 The dietary supplement developed as part of the project will be directed to the markets: Polish and foreign, both retail (sale under own brand (English)
16 October 2020
0 references
Identifiers
RPLD.01.02.02-10-0005/18
0 references